Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by Laura R  – Israel, 2020-03-22 08:58 (308 d 17:55 ago) – Posting: # 21294
Views: 2,319

Hi, was wondering how P1 CROs are dealing with the COVID19 crisis, and if there is any chance to keep studies moving (in small cohorts, no overnight stays, etc).
Should HV studies considered an essential activity per the new FDA/EMA guidances, is voluteering in a Phase 1 study considered a valid reason to be outside? Laura

Complete thread:

 Admin contact
21,310 posts in 4,445 threads, 1,489 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Monday 02:54 CET (Europe/Vienna)

Science may set limits to knowledge,
but should not set limits to imagination.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz